Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001-2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. MAIN RESULTS: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105-143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3-5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02-1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04-10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01-0.38, p = 0.003). CONCLUSIONS: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
WILSON, J. T. L., PETTIGREW, L. E. L., & TEASDALE, G. M. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.573 · Cited by 2,386 · cited 4×
“Assessment of Outcome The primary evaluation criterion was the structured Glasgow Outcome Scale (GOS) score on day 90 (67 days) after onset of PRES (Table 1).”
BackgroundInfluentialCapes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 1×
“Hyperglycaemia, a common occurrence in neurocritical care patients [33], was significantly associated in several studies with increased mortality and impaired functional outcomes after events such as stroke [34,35], intracerebral haemorrhage [36], traumatic brain injury, [37] and spinal cord injury.”
BackgroundA Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391202 · Cited by 1,325
Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., Gottwald, M. D., O'Neil, N., Neuhaus, J. M., Segal, M. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002141 · Cited by 888
It’s time to revise the definition of status epilepticus
Lowenstein, D. H., Bleck, T., & Macdonald, R. L. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02000.x · Cited by 805 · cited 1×
“[17,18] Refractory status epilepticus was defined as continuous or intermittent seizures despite treatment with an intravenous benzodiazepine (clonazepam or diazepam) and intravenous phenytoin, fosphenytoin, or phenobarbital.”
Background
Cited by
Fugate, J. E., & Rabinstein, A. A. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00111-8 · Cited by 1,142
Neurological sequelae and clinical outcomes after lung transplantation
Smith, P. J., Stonerock, G. L., Ingle, K. K., Saulino, C. K., Hoffman, B., Wasserman, B., Blumenthal, J. A., Palmer, S. M., Klapper, J. A., Hartwig, M. G., et al. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000766 · Cited by 30
Metadata
- Authors
- Legriel, S., Schraub, O., Azoulay, E., Hantson, P., Magalhaes, E., Coquet, I., Bretonniere, C., Gilhodes, O., Anguel, N., Megarbane, B., Benayoun, L., Schnell, D., Plantefeve, G., Charpentier, J., Argaud, L., Mourvillier, B., Galbois, A., Chalumeau-Lemoine, L., Rivoal, M., Durand, F., Geffroy, A., Simon, M., Stoclin, A., Pallot, J.-L., Arbelot, C., Nyunga, M., Lesieur, O., Troché, G., Bruneel, F., Cordoliani, Y.-S., Bedos, J.-P., & Pico, F.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-14
- Volume
- 7
- Issue
- 9
- Pages
- e44534
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1975843484
- Cited by
- 204
- References
- 7
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome. https://app.cochat.ai/papers/10.1371/journal.pone.0044534
- The paper
- Legriel, S., Schraub, O., Azoulay, E., Hantson, P., Magalhaes, E., Coquet, I., Bretonniere, C., Gilhodes, O., Anguel, N., Megarbane, B., Benayoun, L., Schnell, D., Plantefeve, G., Charpentier, J., Argaud, L., Mourvillier, B., Galbois, A., Chalumeau-Lemoine, L., Rivoal, M., . . . Pico, F. (2012). Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome. PLoS ONE. https://doi.org/10.1371/journal.pone.0044534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.